tiprankstipranks
Trending News
More News >
Ontrak (OTRK)
NASDAQ:OTRK

Ontrak (OTRK) Price & Analysis

Compare
852 Followers

OTRK Stock Chart & Stats


Financials

OTRK FAQ

What was Ontrak’s price range in the past 12 months?
Ontrak lowest stock price was $0.50 and its highest was $5.53 in the past 12 months.
    What is Ontrak’s market cap?
    Ontrak’s market cap is $2.33M.
      When is Ontrak’s upcoming earnings report date?
      Ontrak’s upcoming earnings report date is Aug 06, 2025 which is in 36 days.
        How were Ontrak’s earnings last quarter?
        Ontrak released its earnings results on May 20, 2025. The company reported -$1.35 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.35.
          Is Ontrak overvalued?
          According to Wall Street analysts Ontrak’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Ontrak pay dividends?
            Ontrak does not currently pay dividends.
            What is Ontrak’s EPS estimate?
            Ontrak’s EPS estimate is -1.08.
              How many shares outstanding does Ontrak have?
              Ontrak has 4,217,848 shares outstanding.
                What happened to Ontrak’s price movement after its last earnings report?
                Ontrak reported an EPS of -$1.35 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.637%.
                  Which hedge fund is a major shareholder of Ontrak?
                  Currently, no hedge funds are holding shares in OTRK

                  Company Description

                  Ontrak

                  Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to health plans and other third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology-enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was incorporated in 2003 and is headquartered in Henderson, Nevada.

                  OTRK Earnings Call

                  Q1 2025
                  0:00 / 0:00
                  Earnings Call Sentiment|Neutral
                  The earnings call highlights Ontrak's significant enrollment growth, operational efficiency improvements, and promising pipeline opportunities, but these are tempered by a notable decline in revenue and gross margin due to customer loss and changes in revenue per member. The company's strategic expansions and partnerships are positive, yet financial metrics indicate challenges remain.Read More>
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Phio Pharmaceuticals
                  GT Biopharma
                  AEON Biopharma
                  Dermata Therapeutics
                  Lipella Pharmaceuticals, Inc.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis